CA Patent

CA2868391A1 — Polynucleotides comprising n1-methyl-pseudouridine and methods for preparing the same

Assigned to Moderna Inc · Expires 2013-10-10 · 13y expired

What this patent protects

The invention relates to compositions and methods for the preparation, manufacture and therapeutic use of polynucleotides, primary transcripts and mmRNA molecules.

USPTO Abstract

The invention relates to compositions and methods for the preparation, manufacture and therapeutic use of polynucleotides, primary transcripts and mmRNA molecules.

Drugs covered by this patent

Patent Metadata

Patent number
CA2868391A1
Jurisdiction
CA
Classification
—
Expires
2013-10-10
Drug substance claim
No
Drug product claim
No
Assignee
Moderna Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.